CREATE
TRANSFORMATIVE
MEDICINES
TRANSFORMATIVE
MEDICINES
Translate biology insights into genetic medicines.
Developing a COVID Vaccine or Therapeutic?
PNI’s COVID-19 Solutions can help you to develop and manufacture RNA nanomedicine vaccines and therapeutics faster and more reliably
We Offer an Integrated Suite of Proprietary Technology, Nanomedicine Expertise & Custom Services:
Scale-up and manufacturing technology for your RNA-LNPs therapeutics
Proprietary lipids formulations (RNA delivery technology) for your formulation
Expertise and support in formulation development, optimization, and planning scale-up and tech transfer for GMP manufacturing
Joint efforts to seek available funding for co-development of COVID-19 RNA-LNP vaccine
Rapidly prepare low-volume nanoparticle formulations with the push of a button on the Spark™ or learn how Formulation Solutions can help with proof-of-concept nanoparticle formulations.
Optimize a wide range of nanomedicine formulations with the NanoAssemblr® Ignite or
the Blaze™
depending on your volumes to allow you to gather the data on the effectiveness, required dosing and safety of a new therapy.
Scalable manufacturing is a significant challenge to making revolutionary medicine and Clinical Solution is ready to assist you in your nanoparticle manufacturing process development.
over
70%
of top pharmaceutical companies work with PNI
200+
instruments are installed
worldwide
80+
biopharmaceutical labs use NanoAssemblr® instruments for nanomedicine
drug development
Innovations that accelerate the drug development journey and enable the production of more sophisticated and powerful nanomedicines is our passion. We don’t do it alone, we pursue strategic collaborations that enable researchers to move quickly
in the drug development process. Contact our Business Development Team.
CaSino Biologics and Precision NanoSystems Announced a Collaboration to Co-Develop a Covid-19 RNA Vaccine
PNI will lead development of the mRNA-LNP vaccine: RNA Vaccine Development, LNP Formulations and NanoAssemblr technology.
Entos and Precision NanoSystems Partner to Enable GMP Manufacturing of DNA COVID-19 Vaccine
"Using their GMP System will let us meet the challenge of producing our pan-coronavirus DNA vaccine at large scale and in as short a time as possible, while exceeding all safety and quality requirements."
John Lewis, Entos CEO
Clinical Solutions Platform Launch
“Clinical Solutions is designed to provide a one-stop-shop for all nanomedicine clinical development needs, such as sourcing GMP excipients, developing analytical methods, building Quality Management Systems or accessing experienced Contract Manufacturing Organizations,” Precision NanoSystems' CCO, Euan Ramsay
Get Started
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.
Get in TouchTechnology
Our exclusive NxGen technology uses precisely controlled mixing to reproducibly generate optimal particles through a single mixer across scales. NxGen technology is at the heart of the NanoAssemblr® family, which provides manufacturing of nanoparticles at different scales suitable for all stages of nanomedicine development.
Areas of Interest
Nanomedicines span many areas of interest. Explore resourceslike papers, application notes, scientific posters, webinars and more to see how nanotechnology is transforming medicine.
You're In Good Company
‹
›
Resource Center
Poster
September 01, 2022
Application Note
March 15, 2022
Publication - Abstract
July 01, 2020
Journal of Controlled Release
Publication - Abstract
May 08, 2020
Vaccines
Publication - Abstract
April 02, 2020
Journal of Controlled Release
Stay Informed
Sign up today to automatically receive new Cytiva, formerly Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.